Literature DB >> 3620290

Prolactin response to low dose sulpiride.

M E McMurdo, P W Howie, M Lewis, M Marnie, J McEwen, A S McNeilly.   

Abstract

1 Prolactin levels in response to sulpiride were studied in healthy volunteers. 2 Oral doses of 1 mg-50 mg sulpiride or placebo were given. 3 A 3 mg sulpiride dose produced similar levels to those achieved with both 10 mg and 50 mg. 4 Circadian effects were studied showing no significant differences in the prolactin response to sulpiride. 5 Acute or chronic responses showed an attenuation with chronic sulpiride treatment to 50% of the peak levels attained with acute treatment. 6 These results indicate that sulpiride retains its potent ability to produce prolactin release even at the low doses studied here.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620290      PMCID: PMC1387741          DOI: 10.1111/j.1365-2125.1987.tb03153.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Effect of two weeks' treatment with thioridazine, chlorpromazine, sulpiride and bromazepam, alone or in combination with alcohol, on learning and memory in man.

Authors:  R Liljequist; M Linnoila; M J Mattila; I Saario; T Seppälä
Journal:  Psychopharmacologia       Date:  1975-10-31

2.  Oral contraceptive agents do not affect serum prolactin in normal women.

Authors:  J R Davis; C Selby; W J Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1984-04       Impact factor: 3.478

3.  Effect of sulpiride on serum prolactin levels in humans.

Authors:  A M Mancini; A Guitelman; C A Vargas; L Debeljuk; N J Aparicio
Journal:  J Clin Endocrinol Metab       Date:  1976-01       Impact factor: 5.958

4.  Unresponsiveness of prolactin to repeated injection of sulpiride in man.

Authors:  H Cohen; M Pugeat; J Tourniaire; J Bertrand
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Augmentation of puerperal lactation by oral administration of sulpiride.

Authors:  T Aono; T Shioji; T Aki; K Hirota; A Nomura; K Kurachi
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

6.  Circadian periodicity of serum prolactin concentration in man.

Authors:  J Nokin; M Vekemans; M L'Hermite; C Robyn
Journal:  Br Med J       Date:  1972-09-02

7.  Prolactin responsiveness to repeated decremental doses of sulpiride.

Authors:  W P Tormey; M P Buckley; W Taaffe; D A O'Kelly; A Darragh
Journal:  Horm Metab Res       Date:  1981-08       Impact factor: 2.936

8.  Sulpiride and the potentiation of progestogen only contraception.

Authors:  M R Payne; P W Howie; A S McNeilly; W Cooper; M Marnie; L Kidd
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

9.  Sulpiride improves inadequate lactation.

Authors:  O Ylikorkala; A Kauppila; S Kivinen; L Viinikka
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-24
  9 in total
  7 in total

1.  Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers.

Authors:  C von Bahr; F A Wiesel; G Movin; P Eneroth; P Jansson; L Nilsson; S Ogenstad
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Influence of the dosing interval on prolactin release after remoxipride.

Authors:  G Movin-Osswald; M Hammarlund-Udenaes; C Von Bahr; P Eneroth; K Walton-Bowen
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

3.  Incidental Findings of Intense Radioiodine Uptake in Struma Ovarii and Bilateral Nonlactating Breasts Simultaneously on Postablation 131I SPECT/CT for Papillary Thyroid Cancer.

Authors:  Hye-Kyung Shim; Mi Ra Kim
Journal:  Nucl Med Mol Imaging       Date:  2016-11-11

4.  A comparison of the neuro-endocrinological and temperature effects of DU 29894, flesinoxan, sulpiride and haloperidol in normal volunteers.

Authors:  P de Koning; M H de Vries
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

5.  Effects of levosulpiride in patients with functional dyspepsia accompanied by delayed gastric emptying.

Authors:  C W Song; H J Chun; C D Kim; H S Ryu; J G Choe; J H Hyun
Journal:  Korean J Intern Med       Date:  1998-02       Impact factor: 2.884

Review 6.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

7.  Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Ma Ludivina Robles-Osorio; Renata García-Franco; Carlos D Núñez-Amaro; Ximena Mira-Lorenzo; Paulina Ramírez-Neria; Wendy Hernández; Ellery López-Star; Thomas Bertsch; Gonzalo Martínez de la Escalera; Jakob Triebel; Carmen Clapp
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-29       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.